Kotak Institutional Equities has issued a BUY recommendation for Syngene International, targeting a fair value of Rs 825, with the current market price at Rs 646.

Deven Choksey Research has issued a BUY recommendation for Granules India Limited, setting a 12-month target of Rs 612 from the current market price of Rs 527, implying a potential upside of 16.2%.

Global healthcare giant GSK PLC (NYSE: GSK) has received a BUY recommendation from Argus Research, with analysts projecting a 14% total return potential through June 2026.

Prabhudas Lilladher has reiterated a BUY call on Aurobindo Pharma with a revised target price of Rs 1,440, underpinned by robust growth in U.S.

Motilal Oswal has reiterated a BUY recommendation on Sun Pharma, assigning a target price of Rs 2,000, implying a 16% upside from its current market price of Rs 1,719.

Lupin has posted a strong Q4FY25 led by momentum in its US portfolio, with ICICI Securities reaffirming a HOLD recommendation and a target price of Rs 2,110, indicating limited upside from the curr